Prophylactic Agents for Preventing Cardiotoxicity Induced Following Anticancer Agents: A Systematic Review and Meta-Analysis of Clinical Trials
CONCLUSION: This meta-analysis showed that prophylactic treatment with cardio-protective drugs, including dexrazoxane, beta blocker, and ACEI drugs in patients undergoing chemotherapy with anthracycline, have a protective effect on LVEF and prevent EF drop.PMID:36803186 | DOI:10.2174/1574887118666230118102252
Source: Reviews on Recent Clinical Trials - Category: Cancer & Oncology Authors: Ehsan Keshavarzian Tella Sadighpour Seyed Mohammadreza Mortazavizadeh Mohammadhossein Soltani Amir Farzin Motevalipoor Shahriyar Shahbazi Khamas Mohammad Moazen Mohamad Kogani Seyed Mohammad Amin Hashemipour Hamid Hosseinpour Rohollah Valizadeh Source Type: research
More News: Beta-Blockers | Bisoprolol | Cancer | Cancer & Oncology | Captopril | Cardiology | Cardiomyopathy | Chemotherapy | Cholesterol | Clinical Trials | Cozaar | Diovan | Enalapril | Heart | Losartan | Science | Spironolactone | Statin Therapy | Study | Toprol